Back to Results
First PageMeta Content
Pharmaceutical industry / Pharmaceutical sciences / Chemistry / Venlafaxine / Phenols / Desvenlafaxine / Bioequivalence / Capsule / Antidepressant / Alcohols / Pharmacology / Clinical research


Microsoft Word - Venlaneo XL 37.5, 75 and 150mg Prolonged-Release Capsules PL 08137_0193-5.doc
Add to Reading List

Document Date: 2009-06-02 12:33:17


Open Document

File Size: 1,22 MB

Share Result on Facebook

Company

Neolab Limited / Brother Limited / Wyeth / Introduction Page 4 Pharmaceutical / /

Country

United Kingdom / /

Facility

PHARMACEUTICAL ASSESSMENT DRUG SUBSTANCE Fluvastatin Sodium INN / /

IndustryTerm

Treatment of generalised anxiety disorder / active pharmaceutical ingredient / pharmaceutical excipients sucrose / reference product / manufacturing method / Treatment of social anxiety disorder / pharmaceutical expert report / Treatment of panic disorder / reference products / hybrid generic medicinal products / generic hybrid medicinal product / abridged standard applications / medicinal products / food / /

MedicalCondition

social anxiety disorder / anxiety disorders / panic disorder / agoraphobia / aluminium foil blister / depression / generalised anxiety disorder / /

Organization

MHRA / European Union / /

Product

venlafaxine / Prolonged-Release Tablets / talc / Efexor 37.5mg Tablets / Prolonged-Release Capsules / /

ProgrammingLanguage

EC / /

Technology

pharmacokinetics / /

SocialTag